Document And Entity Information - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2021 |
Mar. 23, 2022 |
Jun. 30, 2021 |
|
| Document Information Line Items | |||
| Entity Registrant Name | PASITHEA THERAPEUTICS CORP. | ||
| Trading Symbol | KTTA | ||
| Document Type | 10-K/A | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity Common Stock, Shares Outstanding | 22,858,371 | ||
| Entity Public Float | $ 0 | ||
| Amendment Flag | true | ||
| Amendment Description | On March 30, 2022, Pasithea Therapeutics Corp. (the “Company”) filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Original Form 10-K”). This Amendment No. 1 to Form 10-K is being filed solely to: ●correct Part III, Item 11. Executive Compensation, to accurately reflect the grants of stock options and restricted stock units to the Company’s CEO, Dr. Tiago Reis Marques, on December 20, 2021, in accordance with his Executive Employment Agreement; ● correct Part III, Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters – Securities Authorized for Issuance Under Existing Equity Compensation Plans to accurately reflect the grants of stock options and restricted stock units to the Company’s CEO, Dr. Tiago Reis Marques, on December 20, 2021, in accordance with his Executive Employment Agreement; ●file Dr. Marques’ Executive Employment Agreement, dated as of January 1, 2022, as an exhibit under Item 15 of Part IV hereof; ●file Dr. Marques’ Stock Option Agreement, dated as of December 20, 2021, as an exhibit under Item 15 of Part IV hereof; ●file Dr. Marques’ Restricted Stock Unit Agreement, dated as of December 20, 2021, as an exhibit under Item 15 of Part IV hereof; ●file new certifications of our principal executive officer and principal financial officer as exhibits to this Amendment under Item 15 of Part IV hereof, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).Part III, Item 11. Executive Compensation and Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters and Part IV, Exhibits and Financial Statement Schedules are presented in their entirety, as amended. This Amendment does not otherwise change or update any of the other disclosures set forth in the Original Form 10-K and does not otherwise reflect any events occurring after the filing of the Original Form 10-K. | ||
| Entity Central Index Key | 0001841330 | ||
| Entity Current Reporting Status | Yes | ||
| Entity Voluntary Filers | No | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Well-known Seasoned Issuer | No | ||
| Document Period End Date | Dec. 31, 2021 | ||
| Document Fiscal Year Focus | 2021 | ||
| Document Fiscal Period Focus | FY | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | true | ||
| Entity Shell Company | false | ||
| Entity Ex Transition Period | false | ||
| ICFR Auditor Attestation Flag | false | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Entity File Number | 001-40804 | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Tax Identification Number | 85-1591963 | ||
| Entity Address, Address Line One | 1111 Lincoln Road | ||
| Entity Address, Address Line Two | Suite 500 | ||
| Entity Address, City or Town | Miami Beach | ||
| Entity Address, State or Province | FL | ||
| Entity Address, Postal Zip Code | 33139 | ||
| City Area Code | (702) | ||
| Local Phone Number | 514-4174 | ||
| Title of 12(b) Security | Common stock, par value $0.0001 per share | ||
| Security Exchange Name | NASDAQ | ||
| Entity Interactive Data Current | Yes | ||
| Auditor Firm ID | 688 | ||
| Auditor Name | Marcum llp | ||
| Auditor Location | New Haven, CT |